List Title | APhA DrugInfoLine

Drug Interactions Corner

SORT BY: Most Recent Most Viewed

July 16, 2018

Drug interactions are common among older adults receiving antiretroviral therapies

READ

PREVIEW
A cross-sectional observational study published in the Journal of Acquired Immune Deficiency Syndromes involving 744 patients with HIV receiving antiretroviral treatment and at least one...
May 14, 2018

Common antibiotics do not appear to interact with hormonal contraceptives

READ

PREVIEW
Clinical and pharmacokinetic studies do not appear to support an interaction between hormonal contraceptives (HCs) and most nonrifamycin antibiotics (e.g., penicillins/cephalosporins,...
March 13, 2018

PPIs decrease the effectiveness of hepatitis C antivirals

READ

PREVIEW
Sustained virologic responses (SVRs) were lower in patients with hepatitis C taking direct-acting antivirals with proton pump inhibitors (PPIs) compared with those not receiving PPIs, according to...
March 6, 2018

Herb–drug interactions can result in serious adverse drug reactions

READ

PREVIEW
Results of an extensive review demonstrated that use of herbal products by patients taking prescription or OTC medications (e.g., warfarin, statins, immunosuppressants, NSAIDs) resulted in adverse...
December 4, 2017

Drug interactions with newer oral anticoagulants are a concern

READ

PREVIEW
Concurrent use of amiodarone, fluconazole, phenytoin, or rifampin with newer oral anticoagulants (NOACs) such as apixaban (Eliquis—Bristol-Myers Squibb), dabigatran (Pradaxa—Boehringer Ingelheim...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.